Business MediPharm Labs reports 10% drop in Q2 revenue to $4.3M Toronto-based MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) had a revenue decrease of 10 per cent during its last quarter. On Monday,... Natalia Buendia CalvilloAugust 15, 2022
Research MediPharm to supply USC with liquid cannabinoid drug for new study Lead investigators receive US$16M grant to support new research endeavour Rowan DunneAugust 9, 2022
Business Medipharm reports 65% net loss decrease in Q1 The company also reported a 14 per cent decrease in revenue Natalia Buendia CalvilloMay 16, 2022
Business Medipharm Labs acquires Shelter Cannabis brands The firm calls it an 'important step' in building its recreational market portfolio Natalia Buendia CalvilloMarch 22, 2022
Business MediPharm Labs to enter US pharmaceutical market via FDA drug registration If approved, it could advance the firm's goal of becoming a dominant supplier of cannabinoid pharmaceutical ingredients Natalia Buendia CalvilloFebruary 23, 2022